| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2160193 | Radiotherapy and Oncology | 2008 | 4 Pages |
Abstract
Two patients, one with malignant pleural mesothelioma and one with a malignant short spindle cell tumor, received boron neutron capture therapy (BNCT). In each case, the tumors regressed or remained stable in size for 3–6 months following BNCT. No acute or late adverse events higher than grade 2 were observed.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Minoru Suzuki, Kazuo Endo, Hiroaki Satoh, Yoshinori Sakurai, Hiroaki Kumada, Hiroyuki Kimura, Shinichiro Masunaga, Yuko Kinashi, Kenji Nagata, Akira Maruhashi, Koji Ono,